Proteome Sciences plc (AIM:PRM)
London · Delayed Price · Currency is GBP · Price in GBX 1.450
0.00 (0.00%)
Sep 25, 2026, 11:04 AM GMT
Proteome Sciences Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -2.32 | -3.06 | -3.41 | -2.44 | 1.33 | 0.07 |
Depreciation & Amortization | 0.99 | 0.93 | 0.84 | 0.48 | 0.28 | 0.21 |
Stock-Based Compensation | 0 | 0.02 | 0.04 | 0.22 | 0.3 | 0.57 |
Other Operating Activities | 1.1 | 1.09 | 0.88 | 0.81 | 0.59 | 0.27 |
Change in Accounts Receivable | 0.49 | -0.03 | 0.57 | 0.7 | -0.92 | 0.16 |
Change in Inventory | 0.07 | 0.2 | 0.11 | 0.06 | 0.19 | -0.21 |
Change in Accounts Payable | 0.14 | 0.84 | 0.15 | -0.3 | 0.29 | -0.29 |
Change in Other Net Operating Assets | -0.05 | -0.03 | 0 | -0.02 | 0.08 | 0.01 |
Operating Cash Flow | 0.42 | -0.05 | -0.83 | -0.48 | 2.14 | 0.79 |
Operating Cash Flow Growth | - | - | - | - | 169.86% | -49.91% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.06 | -0.1 | -0.22 | -0.24 | -0.32 | -0.2 |
Other Investing Activities | 0 | - | - | -0.19 | - | - |
Investing Cash Flow | -0.05 | -0.1 | -0.22 | -0.42 | -0.32 | -0.2 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 0.65 | 0.75 | - | - | - |
Total Debt Issued | 0.2 | 0.65 | 0.75 | - | - | - |
Short-Term Debt Repaid | - | - | - | -0.82 | - | - |
Long-Term Debt Repaid | - | -0.85 | -0.6 | -0.24 | -0.21 | -0.4 |
Lease Payments | -0.62 | -0.85 | -0.6 | -0.24 | -0.21 | -0.4 |
Total Debt Repaid | -0.62 | -0.85 | -0.6 | -1.06 | -0.21 | -0.4 |
Net Debt Issued (Repaid) | -0.42 | -0.2 | 0.15 | -1.06 | -0.21 | -0.4 |
Issuance of Common Stock | 0.88 | - | - | - | - | - |
Financing Cash Flow | 0.46 | -0.2 | 0.15 | -1.06 | -0.21 | -0.4 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.01 | - | - | - | -0.01 | -0.01 |
Net Cash Flow | 0.84 | -0.35 | -0.9 | -1.97 | 1.61 | 0.18 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0.37 | -0.14 | -1.05 | -0.72 | 1.82 | 0.59 |
Free Cash Flow Growth | - | - | - | - | 209.17% | -62.48% |
Free Cash Flow Margin | 9.68% | -3.81% | -21.49% | -14.28% | 23.41% | 11.48% |
Free Cash Flow Per Share | 0.00 | - | -0.00 | -0.00 | 0.01 | 0.00 |
Levered Free Cash Flow | -0.35 | -0.38 | -0.55 | -0.58 | 0.61 | 0.32 |
Unlevered Free Cash Flow | 0.24 | 0.2 | 0.01 | -0.08 | 0.91 | 0.5 |
Free Cash Flow After Leases | -0.25 | -1 | -1.65 | -0.96 | 1.61 | 0.19 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | - | -0.53 | 0.25 | 0.03 | -0.07 | 0.05 |
Change in Working Capital | 0.65 | 0.98 | 0.83 | 0.45 | -0.36 | -0.33 |